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Abstract
Background: Malaria remains the leading cause of morbidity and mortality in sub-Saharan Africa despite tools currently
available for its control. Making malaria vaccine available for routine use will be a major hallmark, but its acceptance by
community members and health professionals within the health system could pose considerable challenge as has been
found with the introduction of polio vaccinations in parts of West Africa. Some of these challenges may not be expected
since decisions people make are many a time driven by a complex myriad of perceptions. This paper reports knowledge
and perceptions of community members in the Kintampo area of Ghana where malaria vaccine trials have been
ongoing as part of the drive for the first-ever licensed malaria vaccine in the near future.
Methods: Both qualitative and quantitative methods were used in the data collection processes. Women and men
whose children were or were not involved in the malaria vaccine trial were invited to participate in focus group
discussions (FGDs). Respondents, made up of heads of religious groupings in the study area, health care providers,
traditional healers and traditional birth attendants, were also invited to participate in in-depth interviews (IDIs). A
cross-sectional survey was conducted in communities where the malaria vaccine trial (Mal 047RTS,S) was carried out. In
total, 12 FGDs, 15 IDIs and 466 household head interviews were conducted.
Results: Knowledge about vaccines was widespread among participants. Respondents would like their children to be
vaccinated against all childhood illnesses including malaria. Knowledge of the long existing routine vaccines was
relatively high among respondents compared to hepatitis B and Haemophilus influenza type B vaccines that were
introduced more recently in 2002. There was no clear religious belief or sociocultural practice that will serve as a possible
barrier to the acceptance of a malaria vaccine.
Conclusion: With the assumption that a malaria vaccine will be as efficacious as other EPI vaccines, community
members in Central Ghana will accept and prefer malaria vaccine to malaria drugs as a malaria control tool. Beliefs and
cultural practices as barriers to the acceptance of malaria vaccine were virtually unknown in the communities surveyed.
Keywords: Vaccines, Malaria, Perceptions
Background
Malaria is still endemic in sub-Saharan Africa. Plasmo-
dium falciparum malaria is estimated to cause millions
of clinical episodes worldwide with majority in sub-
Saharan Africa [1,2]. In Ghana, the burden of malaria is
high with about 323 per 1,000 cases reported among chil-
dren under five years of age in 2008; there has been some
evidence of a decrease in malaria case in more recent
years [3]. The burden of malaria in Ghana and other
endemic countries leads to anaemia and cerebral malaria,
resulting from severe or uncomplicated malaria if uncon-
trolled. Interventions such as rapid diagnosis, prompt ap-
propriate treatment, intermittent preventive treatment of
pregnant women with sulphadoxine-pyrimethamine, use
of insecticide-treated nets (ITNs) and indoor residual
spraying are beneficial and currently used in routine im-
plementation as part of the strategies to control malaria.
These methods do not exist without challenges. Though
ITNs are known to reduce morbidity [4] and mortality [5],
there are challenges associated with its effective use; these
include net holes and improper use [6]. The use of
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currently available artemisinin combination therapy (ACT)
is also challenged by emerging resistance to artemisinin on
the Thailand-Cambodia border [7].
Vaccines have an excellent, documented, historical rec-
ord showing its ability to protect human population from
diseases; the eradication of smallpox, near elimination of
polio, rare cases of measles and yellow fever [8] are all cir-
cumstantial evidence of what vaccines can do for public
health. An efficacious malaria vaccine will significantly re-
duce the burden of malaria. The RTS,S malaria vaccine is a
pre-erythrocytic malaria vaccine that has been developed
by GlaxoSmithKline (GSK) and is being researched with
sponsorship from Program for Appropriate Technology in
Health/Malaria Vaccine Initiative and GlaxoSmithKline [9].
Clinical trials are ongoing in order to evaluate the safety
and efficacy of the vaccine in sub-Saharan Africa, including
Ghana. So far, the RTS,S malaria vaccine has been found to
be very safe when used among infants and young children
[9]. Its protective efficacy against clinical malaria after one
year post vaccination among infants and children were
about 30% and 50% respectively in phase III trials [9,10].
However, recent efficacy results of the RTS,S malaria
vaccine showed a decline in efficacy rate to 16.8% after
4 years of follow up [11]. It may be introduced as part of
Expanded Programme on Immunization (EPI) for com-
munity use to control malaria following approval by
regulatory authorities.
The introduction of new health interventions, including
vaccines, has been challenging in some settings. A polio
vaccination programme was rejected by community mem-
bers in northern Nigeria was largely due to perception of
religious leaders [12]. In Ghana, community members did
not accept a mass deworming programme [13]. In both
cases, poor community engagements, including a misun-
derstanding of the intervention, have been blamed for
unsuccessful implementation. Knowledge of community
perception of malaria vaccine is therefore required to
adequately plan for the introduction of a malaria vaccine
if approved by regulatory authorities. A cross-sectional
quantitative and qualitative survey was conducted about
community perceptions and knowledge of malaria vac-
cines in RTS,S malaria 47 vaccine trial carried out in the
Kintampo area of Ghana. The main findings of the work
have been reported [14].
Methods
A cross-sectional qualitative and quantitative study was
carried out in August and September 2007 in the
Kintampo North and South districts where phase II RTS,S
malaria vaccine trials were being conducted. No efficacy
results were available at the time the study was carried
out. The districts are located within the forest-savannah
transitional ecological zone in the Brong-Ahafo Region of
Ghana. Together, the Kintampo North and South districts
cover a land surface area of 7,162 sq km, with a resident
population of approximately 140,000, based on the
Kintampo Health and Demographic Surveillance System
(KHDSS) counts [15]; community members are predomin-
antly farmers. Malaria transmission in this part of Ghana is
high with an entomological inoculation rate (EIR) of ap-
proximately 269 infective bites per person per year and an-
nual average parasite prevalence of 50% children under five
years [16]. Anopheles gambie and Anopheles funestus are
identified as effective vectors in the area with similar EIR
[17]. Coverage of the EPI in the area is high: vaccination
coverage for Diptheria pertussis, tetanus, poliomyelitis,
measles, yellow fever and all basic immunization in the
Brong Ahafo Region of Ghana, of which the study area is
part, is over 95% [18]. The majority of inhabitants in this
area will likely initiate treatment for all ailments at
home then continue to the licensed chemical shops and
finally visit a health facility if their health does not im-
prove [19]. There are two public hospitals, three private
clinics, three rural clinics, 12 health centres/clinics and
29 community-based health planning and services
(CHPS) compounds. These facilities provide health ser-
vice delivery to both urban communities and deprived
rural poor.
Qualitative methods
Focus group discussion
Twelve focus group discussions (FGDs) were conducted
among community members in six communities, and 15
in-depth interviews (IDIs) among health professionals and
key stakeholders in health in the same communities
(Table 1). Communities were purposively selected based
on their homogeneities, tribal groupings and geographical
location. Selected communities represent half of the
total number of communities where the Phase II RTS,S
malaria vaccine trial was carried out. One FGD each was
conducted in each of the six communities, separately
among women or men whose children were participants in
this malaria vaccine trial and those whose children were
non-participants. Both female and male participants in the
FGDs were randomly selected from the KHDSS, which
keeps an up-to-date record of the whole resident popula-
tion. Each FGD session was made up of to 12 participants.
It was moderated and recorded for transcription and ana-
lysis. In both FGDs and IDIs there was an assessment of
the knowledge of vaccines and available community ter-
minologies and names of vaccines, knowledge of EPI vac-
cines, their attitudes and perceptions on malaria vaccine if
found and the availability of any sociocultural beliefs about
vaccines. Malaria vaccines were discussed in this survey
with the assumption that its efficacy will be similar to that
of other EPI vaccines.
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Quantitative survey
The household survey involved 466 male and female
household heads in the selected communities involved in
the qualitative study. The KHDSS was used as the sam-
pling frame. A systematic sampling method was used to
select the households in the various communities; half of
the respondents were selected from households involved
in the malaria vaccine trial and the other half were from
households where no child was involved in the malaria
vaccine trial. In each compound, only one household was
selected to represent the compound. Trained field workers
asked questions using a structured questionnaire on
knowledge of vaccines and to document available commu-
nity terminologies and names for vaccines; knowledge of
routine EPI vaccines; their attitudes and perceptions on
malaria vaccine if one is eventually licensed for routine
use and any sociocultural beliefs about vaccines. All re-
spondents consented by signing or thumb printing after
the study objectives, procedures, risk and benefits were
explained to them, In the case of illiterate respondents, a
person designated by the study participant witnessed by
signing the consent form in addition to the respondent’s
thumb print.
Data entry cleaning and analyses
All completed quantitative questionnaires were checked
and logged in the computer laboratory for data processing
and analyses. The quantitative data were analysed using
Stata 10 Software (Stata Corp, Texas, USA). Qualitative
data from IDIs and FGDs were digitally recorded, tran-
scribed verbatim and checked for completeness and accur-
acy. Answers to qualitative questions were grouped and
categorized using QRS NVIVO version 7 qualitative soft-
ware. Responses were analysed to identify emerging themes
that addressed the objectives. Appropriate quotes that best
described the various themes were included as support to
the quantitative findings.
Ethical issues
Ethical approval was sought from the Kintampo Health
Research Centre Institutional Ethics Committee. Commu-
nity entry was by explaining the study’s aims and objec-
tives to key community opinion leaders, followed by all
study participants. The study participants were educated
on their right to be part of the study or withdraw from it
at any point they so wished without suffering any penalty.
All participants willingly and individually gave consent;
the data collected were kept confidential and with no ref-
erence to any study participant.
Results
Characteristics of respondents
A total of 466 household heads were involved in the sur-
vey after approaching 480 households. A majority (over
74.7%) of respondents were in the age range of 29 and 39
years (Table 2). A majority of the respondents were mar-
ried; most respondents were farmers (Table 2). Respon-
dents in the FGDs had similar demographic characteristics
as those involved in the survey. Those selected for the IDIs
were health professionals who had attained at least senior
secondary school education or non-professionals with ei-
ther no formal education or with education up to junior
high school level.
Knowledge of vaccines
Knowledge of vaccines was widespread among participants
in the study. Knowledge however, seemed to be skewed to-
wards vaccines given in the form of injections; there was
some knowledge of the existence of the oral polio vaccine
(OPV), which they admitted is not an injection. Finding a
Table 1 Summary of respondents in in-depth interviews
Category of respondent Other relevant detail of respondents Total number of interviews
Medical Officers Located in public hospital 2
Medical Officer Located in private hospital 1
Traditional birth attendants (TBAs) Trained 1
Traditional birth attendants (TBAs) Untrained 1
Chemical seller Located in a rural community 1
Chemical seller Located in an urban community 1
Traditional healers Located in rural communities 2
Health professionals Located in rural clinics 2
Methodist Reverend Minister To represent Protestant churches 1
Catholic catechist To represent Catholic church 1
Pentecost Reverend Minister To represent Pentecost Charismatic/Churches 1
Leader of an Islamic sect To represent Muslims 1
Total 15
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common local name for vaccines that is acceptable and
understandable by all respondents was not difficult. Local
words like “ntetee” “paniebo” exist as terminologies for vac-
cination. Most respondents knew what vaccines are, as
evidenced in the following contributions made by some re-
spondents in both IDIs and FGDs:
“Vaccines are injections given to children in their
childhood so that any disease that has the possibility
of attacking children become less severe if even they
are attacked.” (FGD, female E)
“I know that vaccines are injections given to prevent
the occurrence of a disease.” (FGD, male E)
Participants differentiated vaccines from medicines given
as injections in hospitals emphasizing the preventive aspect
of vaccines. These observations were made:
“For vaccines, they are taken to prevent the occurrence
of the disease. While those injections that are taken at
hospitals, the sickness occurs before one goes for the
injections.” (FGD, male C)
Knowledge of childhood vaccine-prevented diseases
Over 50% of respondents spontaneously mentioned tuber-
culosis and poliomyelitis vaccines as childhood vaccines
(Table 3).
Perceptions about preventing malaria through
vaccination
There were varied views regarding malaria prevention with
vaccines. While some respondents were quite certain that
malaria could be prevented through vaccination, others
were rather sceptical. This is evidenced in contributions
made by respondents in the IDIs and FGDs:
“In science, there is a saying that you cannot say
never. It can happen but I think it will be very
difficult. The malaria parasite strains change so
rapidly, I think that vaccination could be done but
would work in the short term like every three months
just like tabs for typhoid fever and the rest. Sometimes
you can give it to the person but then it does not last.
Its longevity is not there so they would have to come
and take it again. Because the malaria strains are so
varying and a whole lot of them it have lots of
Table 2 Characteristics of respondents in 2007 household
survey
Characteristics of respondents (N= 466) (%)
Age group
19-23 1.1
24-28 12.4
29-34 36.1
35-39 38.6
40-44 6.0
45-49 4.3
50-54 1.1
55+ 0.4
Education
None 34.3
Primary 18.9
Middle School/Junior Secondary School 38.0
Technical/Commercial/Senior Secondary School 6.2
Post middle/Secretarial 1.5
Post Secondary/Nursing Training 0.4
University/Polytechnic 0.6
Religion
Catholic 16.0
Protestants 13.0
Pentecostal/ Charismatic 23.0
Other Christian 6.9
Moslem 24.0
Traditional 4.7
No Religion 10.3
Other 2.1
Ethnicity
Akan 47.9
Ethnic groups from Northern Ghana 42.3
Other ethnic groups including foreign nationals 9.8
Occupation
Farmer 66.5
Sales 11.8
Skilled manual 9.2
Unskilled manual 8.6
Professional 3.0
Clerical 0.9
Marital status
Married 75.1
Live together 20.6
Widowed 0.2
Table 2 Characteristics of respondents in 2007 household
survey (Continued)
Divorced 0.2
Separated 1.3
Never married 2.6
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properties and biochemical characteristics, so to get a
long-lasting vaccine, it is something we can do but we
have to work harder.” (IDI, health care provider B)
A participant, expressing an opinion about a vaccine’s
ability to prevent malaria made the following remarks in
an IDI:
“Well, it looks strange but we are just hoping especially
once they say the vaccine is just going through phase II
and it is going to phase III. This is because malaria is
endemic and any success in that direction is something
that everybody is yearning for. At the OPD, the daily
OPD register shows that malaria is leading, so many
cases of malaria at least 50% or more. The success of
this vaccine will even curtail our burden at the OPD”.
(IDI, health care provider A)
When the respondent was asked the reason for de-
scribing vaccination to prevent malaria as “strange”, the
following was the response:
“The causative organism is always with us. The
mosquito is always with us. Every time we get bitten by
a mosquito. I do not know how long, whether the
vaccine can stay in the body and produce antibodies
that will not let you get malaria once you are
vaccinated, just like polio which when your body is
exposed to the vaccine you will not get it for your
lifetime. This one looks strange because of the
causative organism, but it looks impossible, but let’s
wait.” (IDI, health care provider A)
A chemical seller made the following remarks when
asked if he believed malaria can be prevented through vac-
cination. He was a sceptical but made mention of a more
multiple approach towards this course to fight malaria:
“Well, it is possible. Chloroquine was a drug which
was used to treat malaria when crystalline [penicillin]
was added but it is now phased out. It [malaria]
disturbs people but they cannot complain. We do not
know what the Pharmacy Council and the Food and
Drugs Board saw about chloroquine and recommend
that it should not be used.” (IDI, chemical seller A)
“I cannot argue about that. As am saying when the
polio vaccine was introduced, the incidence of polio
has stopped among children after vaccination. Also
with the measles vaccine, a mother who refuses to
vaccinate her child is always in trouble whenever the
child suffers an attack. So getting a vaccine for
malaria is possible. Mosquito nets have been
introduced but the incidence of malaria is still high.”
(IDI, chemical seller A)
The survey showed that a large proportion of respon-
dents think malaria can be prevented through vaccin-
ation. Over 90% of the respondents were in this category
(Figure 1).
Reasons were assigned for thinking that malaria can
be prevented through vaccination; the statement below
briefly summarizes the thoughts of participants during a
discussion session:
Table 3 Knowledge about vaccines in 2007 household survey
Vaccine type Local name Yes spontaneous n(%) Yes prompted n(%) No n(%) Do not know n(%)
Tuberculosis “NsamanwaPanie” 171 (36.7) 249 (53.4) 18 (3.9) 28 (6.0)
Poliomyelitis “MbubuePanie 241 (51.7) 187 (40.1) 10 (2.1) 28 (6.0)
DPT No local name 61 (13.0) 315 (67.6) 62 (13.3) 28 (6.0)
Measles NtekyemPanie 244 (52.4) 182 (39.1) 12 (2.6) 28 (6.0)
Hepatitis B Breboyadeepanie 15 (3.2) 339 (72.7) 84 (18.1) 28 (6.0)
Haemophilus influenza type B Hwinemuyadee 130 (2.8) 290 (62.2) 135 (29.0) 28 (6.0)
Yellow fever No local name 162 (34.8) 263 (56.4) 13 (2.8) 28 (6.0)
Figure 1 Respondents’ view on whether malaria can be
prevented through vaccination in 2007 survey.
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“An instance is the incident of polio which has been
reduced through vaccination. I have the belief that
malaria can be eradicated or reduced through
vaccination. This can be seen through the research
being carried out.” (IDI, head of a religious group)
Attitudes towards vaccines for childhood diseases
Respondents’ attitudes about vaccines preventing malaria
were quite positive. There was a general quest for vaccines
for all types of diseases, especially malaria. Respondents in
both FGDs and IDIs mentioned the types of diseases they
want their children vaccinated against:
“Malaria is a sickness that disturbs us a lot. So if
children are protected against malaria it will help us.
Because there are lots of mosquitoes that bite and
cause malaria so that if we prevent the occurrence of
malaria it cannot be severe even if there are mosquito
bites.” (FGD, female A)
“Polio, polio disturbs children a lot, it makes them
very weak.” (FGD, female B)
“With diarrhoea, children vomit and pass out watery
stools so if we prevent it, it will be good.”
(FGD, female B)
Vaccines or drugs for malaria control
As part of learning their attitudes towards vaccines for mal-
aria, respondents were asked whether they preferred vac-
cines or drugs or both for malaria; 65.9% of respondents
preferred vaccines to drugs for malaria control while 26.2%
preferred drugs to vaccines. Few respondents had no pref-
erence for vaccines or drugs (Figure 2).
Responses from both male and female participants on
whether they will allow their children to be vaccinated
against malaria, assuming a malaria vaccine is found,
were very insightful:
“I will agree: I have no drugs to cure my children. So if
the government says a disease is about to break out so
I should vaccinate my child, what can I say?”
(FGD, female E)
“Malaria is the number one killer diseases among
children so if it is going to be prevented, then I think
everyone would be happy to include his/her child.”
(FGD, male A)
Diseases that respondents wanted their children vacci-
nated against were confirmed in the survey (Table 4).
These were affirmed by some of the responses in the
FGDs, thus emphasizing how generalized some of the
contributions made by participants in the FGDs could
be when it came to the diseases participants will or will
not want their children to be vaccinated against (Table 4).
Among health care providers and community religious
leaders it was evident that vaccinating children against mal-
aria will be a major breakthrough in science and accepting
it will not be very challenging at the community level:
“I will readily recommend that because malaria in
children under five is fatal. Cerebral malaria for
instance causes lots of problems. In children under-five
, because of their immune system, when they get
malaria it is fatal because of its added complications.
Should we make a head way with this vaccine trial, I
think all children, most especially, children under five
should be vaccinated.” (IDI, health care provider)
“Readily yes or even should I say a big yes. You see, these
children are exposed to lots of filth and as you can see
Figure 2 Preference between vaccines and drugs for malaria in 2007 survey.
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lots of weeds around that serve as breading grounds for
mosquitoes. So getting a vaccine to prevent the effects of
these mosquito bites will be a good thing. I will
recommend it.” (IDI, head of a religious group)
Beliefs and cultural practices about vaccines
The success of disease control programmes to a large ex-
tent depends on the beliefs and cultural practices of the
people who are directly involved in the programme and this
shapes their behaviour and consequently their decision-
making processes. Though beliefs and cultural practices
that will prevent parents from vaccinating their children
were not mentioned, some IDI sessions revealed some in-
teresting points are quoted below:
“……..somewhere in the north, when a child is born it
is not brought out until after one month or so. So if we
are looking at a vaccine targeting children of four
weeks or less, that can possibly be a barrier to such
children getting access to the vaccine. Another one is
the social barrier where women cannot take decision
about their children.” (IDI, health care provider)
“As a Catechist who is in charge of organizing the
congregation here, I always advise women who take
their children to “weighing” [child welfare clinics].” In
the olden days herbs were used to treat diseases but
now it is a thing of the past. We also advise against
the belief that sickness is caused by gods. For now, it is
only medication that is given which in the name of
Jesus we also pray to support I don’t know of any such
beliefs. In the beginning of the trial [RTSS malaria
vaccine trial], some people from the north living here
did not understand that there is the need send the
child for immunization and weighing.”
(IDI, religious leader)
“There is nothing like that [cultural beliefs] if you
should follow these things all your children will die.”
(FGD, male C)
Some religious dimension was given by a participant
when asked if he will recommend vaccination for malaria:
“I know that God has poured his grace on a group of
people who are working through the Holy Spirit. They
are doctors. As the Bishop or any church member goes
to the hospital when sick, if a vaccine for malaria is
found I will not prevent people or any of my church
members from sending their children for vaccination.”
(IDI, head of a religious group)
Among the Muslim participants, the situation about
recommending vaccines for malaria was not very differ-
ent. A participant had this to say:
“Even the prophet Mohammed (‘peace be on him’)
implored his followers to do two important things:
learning very well so that you can worship your God;
learning about protecting yourself from falling sick. It
will have been welcome news to be able to protect
ourselves against diseases. Even God approves of that.
People should actually treat themselves when they are
sick. It is also mentioned in the Quoran that people
should protect themselves from falling sick. It is good
to “defend” yourself from sickness. This is better than
allowing the disease to attack you before you treat it.
Yes, the Quoran does not forbid vaccination. Quoran
is totally in support of prevention. I will readily
recommend, if even it means talking about it in the
various mosques that are under my jurisdiction. I will
even mobilize other Imams working under me, so we
can educate people.” (IDI, head of a religious group)
The call for well-researched studies on a malaria vaccine
Community members called for research as the basis for
acceptance or otherwise of a malaria vaccine, if one is
found. The following observation was made in this regard:
“If research proves that vaccines can be used, then you
can use it. If research does not prove that vaccines can
Table 4 Diseases that respondents will want their children vaccinated against (2007 household survey)
Disease type Local name Yes spontaneous n (%) Yes prompted n(%) No n(%) Do not know n(%)
Malaria “Atiridie” 361 (77.6) 75 (16.0) 3 (0.6) 27 (5.8)
“Hot body” “Ahoohyee” 175 (37.6) 242 (51.9) 21 (4.5) 27 (5.8)
Cough or other respiratory problems “Ewa” 112 (24.0) 275 (59.0) 52 (11.2) 27 (5.8)
Diarrhoea “Ayamtuo” 85 (18.2) 282 (60.5) 72 (15.5) 27 (5.8)
Childhood rashes “Nsawansawa” 66 (12.9) 345 (74.0) 34 (7.3) 27 (5.8)
Measles “Ntenkyem” 240 (51.5) 188 (40.3) 11 (2.4) 27 (5.8)
Abdominal pains “Yafunuyadee” 38 (8.2) 330 (70.8) 71 (15.2) 27 (5.8)
Tuberculosis “Nsamanwa” 183 (39.2) 236 (50.6) 20 (4.3) 27 (5.8)
Convulsion “Esoro” 111 (23.8) 288 (61.8) 40 (8.6) 27 (5.8)
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prevent that disease then you do not have to use it. So
every disease that research proves to be preventable
with vaccines you can vaccinate to prevent it”.
(FGD, male E)
“We want vaccines for communicable diseases but not
for other diseases that we can buy drugs at home to cure.
For instance, when you suffer from headache, if you find
a drug vendor around, you can buy some drugs. Also
when you suffer from stomach aches, you can equally buy
drugs from vendors. These do not require vaccines as they
are not communicable.” (FGD, male E)
Some concerns expressed about the trial
Some participants expressed worry about the volume
and frequency of blood taken from their children for la-
boratory analysis and delays at the trial facilities. They
were however quick to add that they knew the processes
were legitimate for the study as indicated below:
My child is not in the trial but because of this blood
draw someone withdrew the child from the study. So I
went to the person and explained him that in this
trial, it is difficult to even lose a child and if even one
child dies it will be a drawback to the work . People
may think it is because of the blood draw, the blood is
only used to do some investigation, it is not that it is
going to be given to any elderly person or it is going to
be sold.” (FGD, male C)
“I think the blood drawn is for the test of the child’s
own health. For example, when they were enrolling the
children for the study, my child was screened and
because he had some health problems as the result of
the blood test stated, I was made aware that because
of that my child was not going to be enrolled into the
study and I agreed.” (FGD, female E)
Discussion
Understanding the local context of diseases and the
communities’ perceptions of the experimental interven-
tions serves as prerequisite for how the intervention will
be accepted and utilized when it becomes a policy that
has to be implemented as a programme. Several studies
have documented the need and how best to educate
communities [20-23]. This study’s findings, which are
similar to studies documented on the need to under-
stand the local context of diseases, have benefited from
the experiences of such studies and has identified find-
ings as an important step in ensuring the malaria vac-
cine will be acceptable to communities where this was
tested and serve as the springboard for integrating the
vaccine into other communities that did not necessarily
participate in the trials.
It is significant to understand how community members
perceive a malaria vaccine in order to inform the country’s
malaria control managers and officials responsible for the
EPI for planning purposes.
Our results are similar to that found in Kenya [20].
Knowledge of childhood vaccinations was widespread
among respondents. Local names were provided for them,
and this could have some positive effects on childhood
immunization programmes. Caregivers will at given times
be able state which immunizations their children had re-
ceived and those that they have not received. However in
some parts of Mozambique, caregivers mentioned vac-
cines that do not currently exist [24], and this could have
some negative effect on childhood immunization and
overall child care.
The perception of a malaria vaccine as a preventive tool
was similar to that found in a study in the south coast and
the Busia districts of Kenya; respondents were however
more guarded on the possibility of a malaria vaccine [20].
The role of religious beliefs in shaping perceptions and
consequently decisions need not be over emphasized. Reli-
gious beliefs have the potential of diluting community per-
ceptions on a given phenomenon. The boycott of the
polio vaccination programme in some parts of Nigeria was
partly because of the belief that the vaccine could be con-
taminated with anti-fertility, HIV and cancerous agents.
This was mainly a concern held by Muslim clerics in
Muslim-dominated states and by the Supreme Council for
Sharia in Nigeria (SCSN) [12]. Unlike the Nigerian inci-
dent, this study revealed a contrary position; religious be-
liefs that could serve as a potential barrier to the
acceptance of a malaria vaccine were virtually unknown in
the study area, not even among religious leaders. Religious
leaders could therefore be a conduit for a mass introduc-
tion of malaria vaccines. In this study there was a commu-
nity belief children should not be seen until they are more
than a month old. In a recent study in Mozambique it was
reported that a common taboo among some communities
was that a newborn should have limited exposure to adults
with “hot bodies” and “hot blood” [24]. The belief about
exposure of newborns was not limited to adults only, as
reported in the Mozambique study. This belief however is
unlikely to affect the administration and coverage of new
vaccines, such as malaria vaccines, since some known
childhood immunizations such as OPV are given within
the first month of life and their coverages are high. Women
who deliver carry their children to immunization points for
such immunization schedules.
The contribution of the environment is key when chron-
icling factors that contribute to the breeding of mosquitoes.
Recent evidence in Tanzania showed that most vector con-
trol measures target life-threatening mosquitoes through
the use of chemicals belonging to the pyrethroid class; how-
ever resistance of mosquito populations to the pyrethroid
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class of chemicals is increasing dramatically [23]. Commu-
nity members recognized the role the environment plays in
the breeding of mosquitoes. They recognized challenges to
malaria vector control, especially when there is growing
resistance to available insecticides by mosquitoes. They
will therefore welcome a vaccine as one of the ways of
surmounting this problem.
The popularity of vaccines against tuberculosis, measles
and poliomyelitis compared to hepatitis B and Haemophi-
lus influenza type B vaccines is because the former vac-
cines have been in existence over several years compared
to the latter. Similar experience was found among Hong
Kong Chinese adults, where insufficient awareness of
hepatitis B infection was observed. The poor knowledge of
this infection may have resulted from the poor knowledge
of the universal neonatal and adult hepatitis B vaccination
[25]. Health managers and professionals should be aware
of the results of this study and revamp their effort towards
education on the relatively new vaccines.
The study was conducted at the time when malaria effi-
cacy results were unavailable. The knowledge and percep-
tions of malaria vaccines were therefore assessed with the
assumption that its efficacy will be as high as that of other
childhood vaccines. It is likely that the perception of mal-
aria vaccines and their acceptability would be different if
respondents were aware of the current relatively lower ef-
ficacy results of malaria vaccines compared to other child-
hood vaccines [11]. It is therefore important for further
studies to be conducted in the context of current malaria
vaccine efficacy results.
Limitation
In light of the high illiteracy levels of respondents, it was
not possible to conduct interviews in English. FGDs and
some IDIs were conducted in “Akan” (the main local lan-
guage). Thus, some questions had to be reframed when the
respondents had difficulty in understanding. Some respon-
dents lacked in-depth understanding of the local language
and may not have satisfactorily expressed themselves. The
responses may not completely reflect the perceptions of
communities where none of the vaccine trial(s) have taken
place. It will be useful to carry out similar interviews in
communities outside the Kintampo study area in order to
document the views of such communities.
Conclusions
Most respondents will want their children vaccinated
against malaria as part of routine vaccinations. Knowledge
of the EPI vaccines was common among the study popula-
tion. They could distinguish easily between those that are
given as injection and those that are given through other
forms. A large number of respondents in the study wish
their children to be vaccinated for all the known diseases
covered by the EPI. Comparatively greater number of
respondents preferred vaccines to drugs for malaria con-
trol assuming the vaccine is highly efficacious. Beliefs and
cultural practices that will serve as barriers to the accept-
ance of a malaria vaccine were virtually unknown.
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